{"id":"armour-thyroid","safety":{"commonSideEffects":[{"rate":null,"effect":"Tachycardia"},{"rate":null,"effect":"Palpitations"},{"rate":null,"effect":"Tremor"},{"rate":null,"effect":"Anxiety"},{"rate":null,"effect":"Insomnia"},{"rate":null,"effect":"Heat intolerance"},{"rate":null,"effect":"Weight loss"},{"rate":null,"effect":"Headache"}]},"_chembl":null,"_dailymed":{"setId":"56b41079-60db-4256-9695-202b3a65d13d","title":"ARMOUR THYROID (THYROID, PORCINE) TABLET [ALLERGAN, INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Armour Thyroid is a natural desiccated thyroid extract containing both thyroxine (T4) and triiodothyronine (T3) in a ratio approximating the natural thyroid secretion. These hormones bind to thyroid hormone receptors in target tissues, increasing metabolic rate, thermogenesis, and protein synthesis. It is used as replacement therapy in hypothyroidism to restore normal thyroid hormone levels and alleviate symptoms of thyroid deficiency.","oneSentence":"Armour Thyroid replaces deficient thyroid hormones by providing a combination of T4 (levothyroxine) and T3 (liothyronine) derived from desiccated porcine thyroid tissue.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:29:22.732Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypothyroidism (primary, secondary, and tertiary)"},{"name":"Myxedema"}]},"trialDetails":[{"nctId":"NCT01660984","phase":"","title":"Natural History Study of Children and Adults With Medullary Thyroid Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2012-07-30","conditions":"Medullary Thyroid Cancer","enrollment":259},{"nctId":"NCT02152995","phase":"PHASE2","title":"Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2014-08-14","conditions":"Metastatic Thyroid Gland Carcinoma, Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma","enrollment":34},{"nctId":"NCT00001159","phase":"","title":"Natural History of Thyroid Function Disorders","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"1977-02-01","conditions":"Hyperthyroidism, Hypothyroidism, Grave's Disease","enrollment":2500},{"nctId":"NCT07485569","phase":"PHASE1","title":"Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial","status":"NOT_YET_RECRUITING","sponsor":"Radboud University Medical Center","startDate":"2026-06-01","conditions":"Thyroid Cancer Stage IV, Anaplastic Thyroid Cancer, Differentiated Thyroid Cancer","enrollment":10},{"nctId":"NCT06207188","phase":"","title":"Identification and Differentiation of Thyroid Nodules by Acoustic Imaging and Viscoelastic Parameters","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2009-05-17","conditions":"Thyroid Gland Carcinoma","enrollment":650},{"nctId":"NCT07494474","phase":"","title":"Risk Assessment of Pancreatic Islet Autoimmunity in Patients With AITD","status":"NOT_YET_RECRUITING","sponsor":"Nanjing Medical University","startDate":"2026-08-31","conditions":"Autoimmune Thyroid Disease","enrollment":834},{"nctId":"NCT04615988","phase":"","title":"Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2021-06-09","conditions":"Thyroid, PD-1, Cancer","enrollment":17},{"nctId":"NCT07496684","phase":"","title":"Application and Evaluation of Vision-LSTM Modeling in Diagnostic Ultrasound Imaging of TI-RADS Category 4b Thyroid Nodules","status":"COMPLETED","sponsor":"Ma Zhe","startDate":"2022-01-01","conditions":"Thyroid Cancer","enrollment":401},{"nctId":"NCT07498387","phase":"NA","title":"Management of Catatonic Features in Adolescents With Profound Autism","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tanta University","startDate":"2026-01-01","conditions":"Autism Spectrum Disorder, Catatonia","enrollment":30},{"nctId":"NCT06465017","phase":"NA","title":"ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer","status":"TERMINATED","sponsor":"The First Affiliated Hospital of Xiamen University","startDate":"2024-01-04","conditions":"Tumor, Solid Tumor, Thyroid Cancer","enrollment":149},{"nctId":"NCT04234113","phase":"PHASE1","title":"Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors","status":"TERMINATED","sponsor":"SOTIO Biotech AG","startDate":"2019-06-13","conditions":"Thyroid Cancer, Renal Cell Carcinoma, Non Small Cell Lung Cancer","enrollment":115},{"nctId":"NCT06007924","phase":"PHASE2","title":"A Study of Avutometinib and Defactinib in People With Thyroid Cancer","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2023-08-16","conditions":"Thyroid Cancer","enrollment":30},{"nctId":"NCT01005654","phase":"","title":"Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2009-10-07","conditions":"Endocrine Tumors, Thyroid Neoplasms, Parathyroid Neoplasms","enrollment":2415},{"nctId":"NCT06991738","phase":"PHASE1, PHASE2","title":"177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer","status":"NOT_YET_RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2026-04-01","conditions":"Thyroid Cancer","enrollment":18},{"nctId":"NCT03914300","phase":"PHASE2","title":"Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-02-10","conditions":"Differentiated Thyroid Gland Carcinoma, Follicular Variant Thyroid Gland Papillary Carcinoma, Poorly Differentiated Thyroid Gland Carcinoma","enrollment":11},{"nctId":"NCT04439292","phase":"PHASE2","title":"Testing Trametinib and Dabrafenib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol H)","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2015-08-12","conditions":"Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm","enrollment":35},{"nctId":"NCT05024214","phase":"PHASE1, PHASE2","title":"Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors","status":"RECRUITING","sponsor":"3D Medicines (Sichuan) Co., Ltd.","startDate":"2021-11-15","conditions":"Solid Tumors, Non-small Cell Lung Cancer, Renal Cell Carcinoma","enrollment":170},{"nctId":"NCT07491991","phase":"PHASE4","title":"Effects of Different Drugs for Glottic Atomization on Postoperative Sore Throat After Thyroid Surgery","status":"COMPLETED","sponsor":"Qianfoshan Hospital","startDate":"2025-03-02","conditions":"Postoperative Pain, NEBULIZATION, Thyroid Surgery","enrollment":96},{"nctId":"NCT05982821","phase":"NA","title":"Artificial Intelligence-assisted Contrast-enhanced Ultrasound Diagnosis of Thyroid Nodules","status":"COMPLETED","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2023-06-03","conditions":"Thyroid Nodule","enrollment":1955},{"nctId":"NCT02650401","phase":"PHASE1, PHASE2","title":"Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2016-05-03","conditions":"Solid Tumors, CNS Tumors","enrollment":69},{"nctId":"NCT07490964","phase":"","title":"Polycystic Ovary Syndrome in Type 1 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal","startDate":"2026-04-01","conditions":"Type 1 Diabetes Mellitus, Polycystic Ovary Syndrome (PCOS)","enrollment":60},{"nctId":"NCT06727604","phase":"PHASE2","title":"A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease","status":"RECRUITING","sponsor":"Immunovant Sciences GmbH","startDate":"2024-12-17","conditions":"Graves' Disease","enrollment":240},{"nctId":"NCT00001160","phase":"","title":"Studies on Tumors of the Thyroid","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"1977-06-01","conditions":"Hurthle Cell Thyroid Cancer, Tall Cell Variant Thyroid Cancer, Follicular Thyroid Cancer","enrollment":2500},{"nctId":"NCT07491601","phase":"NA","title":"PRESS -PAR: Early Detection and PREvention of Symptomatic postSurgical hypoPARathyroidism After Thyroid Surgery\"","status":"RECRUITING","sponsor":"Nicolas Schlegel","startDate":"2025-01-08","conditions":"Postoperative Hypoparathyroidism, Postsurgical Hypoparathyroidism, Hypoparathyroidism Post-surgical","enrollment":336},{"nctId":"NCT06269393","phase":"PHASE3","title":"A Study of IBI311 in Subjects With Steroid-resistant, Thyroid Associated Ophthalmopathy","status":"COMPLETED","sponsor":"Peking University People's Hospital","startDate":"2024-01-01","conditions":"Thyroid Associated Ophthalmopathy","enrollment":53},{"nctId":"NCT07255482","phase":"","title":"Mortality Benefit of Ultrasound for Thyroid Nodules Identified With PET Imaging: Non-Inferiority Emulated Target Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2025-10-15","conditions":"Thyroid Nodule (Benign), Thyroid Nodule (Diagnosis), Thyroid Cancer","enrollment":5000},{"nctId":"NCT06423235","phase":"PHASE4","title":"Efficacy and Safety of Prunella Oral Liquid in the Treatment of Thyroid Nodules","status":"RECRUITING","sponsor":"Xintian Pharmaceutical","startDate":"2024-07-30","conditions":"Thyroid Nodule","enrollment":234},{"nctId":"NCT06475989","phase":"PHASE3","title":"Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer","status":"RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2024-08-22","conditions":"Refractory Differentiated Thyroid Gland Carcinoma","enrollment":264},{"nctId":"NCT05059470","phase":"PHASE2","title":"IMRT Followed by Pembrolizumab in the Adjuvant Setting in Anaplastic Cancer of the Thyroid (IMPAACT): Phase II Trial Adjuvant Pembrolizumab After IMRT in ATC","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2022-02-11","conditions":"Thyroid","enrollment":6},{"nctId":"NCT06220656","phase":"NA","title":"TRAIL Study: Feasibility and Pilot","status":"RECRUITING","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2025-05-01","conditions":"Thyroid Nodule, Thyroid Neoplasms, Thyroid Cancer","enrollment":20},{"nctId":"NCT07488858","phase":"NA","title":"Thyroidectomy: Microscopic Versus Conventional","status":"COMPLETED","sponsor":"Shahida Islam Medical Complex","startDate":"2025-12-16","conditions":"Thyroid Cancer, Thyroid Surgeries","enrollment":74},{"nctId":"NCT07488325","phase":"","title":"Multimodal Assessment of Malignancy in Atypia of Undetermined Significance in Thyroid Nodules Using Ultrasound and Cytology Whole-Slide Images","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2026-03-01","conditions":"Thyroid Nodule","enrollment":396},{"nctId":"NCT03244956","phase":"PHASE2","title":"Efficacy of MEK (Trametinib) and BRAFV600E (Dabrafenib) Inhibitors With Radioactive Iodine (RAI) for the Treatment of Refractory Metastatic Differentiated Thyroid Cancer","status":"COMPLETED","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2017-12-27","conditions":"Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation","enrollment":40},{"nctId":"NCT06146764","phase":"","title":"CEUS Improves the Diagnostic Performance of SRSS of Thyroid Carcinoma","status":"RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2023-03-18","conditions":"Thyroid Nodule, Thyroid Carcinoma","enrollment":800},{"nctId":"NCT07488585","phase":"NA","title":"This Study Tests a New Sound Blade Ultrasound for Thyroid Scans. It Compares Its Images With Regular Hospital Ultrasounds to See Which is Clearer. The Images Will Help Build Future AI Tools to Improve Care.","status":"NOT_YET_RECRUITING","sponsor":"Sound Blade Medical Inc.","startDate":"2026-05-31","conditions":"Thyroid Nodules, Thyroid Abnormalities","enrollment":30},{"nctId":"NCT03647358","phase":"PHASE1","title":"Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2018-08-21","conditions":"Thyroid Carcinoma, Metastatic Thyroid Carcinoma","enrollment":60},{"nctId":"NCT04927416","phase":"PHASE2","title":"The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2021-10-25","conditions":"Metastic Thyroid Cancer","enrollment":54},{"nctId":"NCT07142005","phase":"","title":"Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer","status":"SUSPENDED","sponsor":"M.D. Anderson Cancer Center","startDate":"2025-08-15","conditions":"Medullary Thyroid Cancer (MTC), Cultural Adaptation","enrollment":40},{"nctId":"NCT06316895","phase":"","title":"The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma","status":"RECRUITING","sponsor":"Chinese PLA General Hospital","startDate":"2024-04-01","conditions":"Papillary Thyroid Cancer","enrollment":3772},{"nctId":"NCT01247597","phase":"","title":"DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2011-02-13","conditions":"Pleuropulmonary Blastoma, Cystic Nephroma, Ovarian Sertoli-Leydig Cell Tumors","enrollment":1500},{"nctId":"NCT06959511","phase":"PHASE2","title":"Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2025-07-22","conditions":"Neoadjuvant Treatment, Thyroid Cancer","enrollment":45},{"nctId":"NCT06465108","phase":"PHASE2","title":"Safety, Pharmacokinetics and Efficacy of MBX 2109 in Patients With Hypoparathyroidism","status":"COMPLETED","sponsor":"MBX Biosciences","startDate":"2024-08-08","conditions":"Hypoparathyroidism","enrollment":64},{"nctId":"NCT06969716","phase":"","title":"Frequency of Fibromyalgia Syndrome in Elderly Patients Aged 80 and Above and Its Relationship With Geriatric Parameters","status":"COMPLETED","sponsor":"Sultan 1. Murat State Hospital","startDate":"2025-05-01","conditions":"Fibromyalgia, Old Age; Debility","enrollment":420},{"nctId":"NCT04211337","phase":"PHASE3","title":"A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Loxo Oncology, Inc.","startDate":"2020-02-11","conditions":"Medullary Thyroid Cancer","enrollment":291},{"nctId":"NCT06731764","phase":"PHASE2, PHASE3","title":"Novel Approaches to the Treatment of Hypothyroidism","status":"RECRUITING","sponsor":"UConn Health","startDate":"2024-12-10","conditions":"Hypothyroidism","enrollment":90},{"nctId":"NCT06340945","phase":"NA","title":"The Outcomes of Ultrasound-guided Thermal Ablation for Benign Thyroid Nodules","status":"RECRUITING","sponsor":"Chinese PLA General Hospital","startDate":"2024-04-01","conditions":"Thyroid Nodules","enrollment":1500},{"nctId":"NCT07480993","phase":"","title":"Serum Betatrophin Levels in Normal-Weight and Overweight Adolescents With PCOS","status":"COMPLETED","sponsor":"Ankara City Hospital Bilkent","startDate":"2026-01-15","conditions":"Polycystic Ovary Syndrome (PCOS), Betatrophin, Body Mass Index (BMI)","enrollment":90},{"nctId":"NCT07400757","phase":"NA","title":"Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease","status":"NOT_YET_RECRUITING","sponsor":"Taipei Veterans General Hospital, Taiwan","startDate":"2026-02-20","conditions":"Thyroid Eye Disease, TED, Graves Ophthalmopathy","enrollment":120},{"nctId":"NCT07480720","phase":"","title":"Systemic Inflammation, Thyroid Autoimmunity and Neuroretinal Changes in Graves Disease","status":"RECRUITING","sponsor":"Elazıg Fethi Sekin Sehir Hastanesi","startDate":"2026-03-01","conditions":"Graves Disease, Graves Ophthalmopathy","enrollment":100},{"nctId":"NCT07054541","phase":"PHASE4","title":"A Novel Echocardiography-Guided Strategy for Percutateous Closure of Atrial Septal Defect Assisted by PannaWire","status":"NOT_YET_RECRUITING","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2026-03-14","conditions":"Atrial Septal Defect (ASD)","enrollment":666},{"nctId":"NCT07092514","phase":"PHASE2","title":"Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differentiated Thyroid Cancer (DTC)","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2025-10-14","conditions":"Thyroid Cancer, Cancer of the Thyroid","enrollment":34},{"nctId":"NCT07288138","phase":"PHASE2","title":"A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)","status":"RECRUITING","sponsor":"Eccogene","startDate":"2025-12-15","conditions":"Metabolic Dysfunction-associated Steatohepatitis","enrollment":160},{"nctId":"NCT07471997","phase":"NA","title":"Triamcinolone Acetonide Injection for Upper Eyelid Retraction in Thyroid Eye Disease","status":"COMPLETED","sponsor":"Instituto de Oftalmología Fundación Conde de Valenciana","startDate":"2024-06-20","conditions":"Thyroid Eye Disease, TED","enrollment":15},{"nctId":"NCT06307613","phase":"PHASE3","title":"A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease","status":"TERMINATED","sponsor":"argenx","startDate":"2024-03-27","conditions":"Thyroid Eye Disease","enrollment":102},{"nctId":"NCT07473518","phase":"","title":"Thyroid Carcinoma in Cancer Patients Undergoing Radiotherapy","status":"RECRUITING","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","startDate":"2025-07-30","conditions":"Thyroid Carcinoma, Pediatric Cancer","enrollment":2550},{"nctId":"NCT06307626","phase":"PHASE3","title":"A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease.","status":"TERMINATED","sponsor":"argenx","startDate":"2024-03-28","conditions":"Thyroid Eye Disease","enrollment":105},{"nctId":"NCT00107289","phase":"PHASE2","title":"Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2006-05","conditions":"Neuroblastoma, Pheochromocytoma","enrollment":200},{"nctId":"NCT03360890","phase":"PHASE2","title":"Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Chicago","startDate":"2018-03-26","conditions":"Thyroid Cancer, Salivary Gland Cancer","enrollment":46},{"nctId":"NCT07470489","phase":"PHASE2","title":"A Multi-Center Single-Arm Phase 2 Trial Of Zanzalintinib In Combination With Cemiplimab In BRAF Wild-Type Anaplastic Thyroid Cancer: The ZEPHYR Trial","status":"NOT_YET_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2026-09-30","conditions":"Anaplastic Thyroid Cancer","enrollment":12},{"nctId":"NCT06507878","phase":"","title":"Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Registry of Oncologic Outcomes With Testing and Treatment.","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2024-12-05","conditions":"Thyroid Cancer","enrollment":459},{"nctId":"NCT06980649","phase":"PHASE1","title":"Study of BHV-1300 in Graves' Disease","status":"RECRUITING","sponsor":"Biohaven Therapeutics Ltd.","startDate":"2025-08-21","conditions":"Graves Disease","enrollment":15},{"nctId":"NCT06728735","phase":"","title":"Role of Next Generation Sequencing in the Etiological Diagnosis of Permanent Congenital Hypothyroidism With in Situ Thyroid","status":"RECRUITING","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","startDate":"2021-03-17","conditions":"Congenital Hypothyroidism","enrollment":350},{"nctId":"NCT07465068","phase":"NA","title":"The Effect of Visceral Osteopathic Manual Therapy in Lumbar Disc Herniation","status":"COMPLETED","sponsor":"Istanbul Rumeli University","startDate":"2025-04-10","conditions":"Disk Hernisi, Visseral Manuel Terapi","enrollment":40},{"nctId":"NCT03753919","phase":"PHASE2","title":"Durvalumab Plus Tremelimumab for the Treatment of Patients With Progressive, Refractory Advanced Thyroid Carcinoma -The DUTHY Trial","status":"TERMINATED","sponsor":"Grupo Espanol de Tumores Neuroendocrinos","startDate":"2019-04-02","conditions":"Metastatic Thyroid Papillary Carcinoma, Metastatic Thyroid Follicular Carcinoma, Metastatic Thyroid Cancer","enrollment":79},{"nctId":"NCT07140757","phase":"","title":"Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2025-08-18","conditions":"Low Risk, Papillary Thyroid Cancer, Radiofrequency Ablation","enrollment":50},{"nctId":"NCT07462195","phase":"PHASE4","title":"Dexmedetomidine for Improving Emergence Quality in Thyroid Surgery","status":"NOT_YET_RECRUITING","sponsor":"Bach Mai Hospital","startDate":"2026-03","conditions":"Thyroid Diseases","enrollment":100},{"nctId":"NCT07459959","phase":"PHASE1, PHASE2","title":"LiO-AD: Lithium Orotate in Alzheimers Disease Feasibility, Biomarker Engagement, and Clinical Response","status":"NOT_YET_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-06-01","conditions":"Alzheimer s Disease","enrollment":40},{"nctId":"NCT07462130","phase":"PHASE1, PHASE2","title":"An Efficacy and Safety Study of NTB003 in Participants With Thyroid Eye Disease (TED)","status":"NOT_YET_RECRUITING","sponsor":"Nanjing Chia-tai Tianqing Pharmaceutical","startDate":"2026-03-01","conditions":"Thyroid Eye Disease","enrollment":74},{"nctId":"NCT04742608","phase":"","title":"Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer","status":"RECRUITING","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2020-02-21","conditions":"Thyroid Gland Carcinoma, Thyroid Gland Nodule","enrollment":250},{"nctId":"NCT07449260","phase":"","title":"Association Between Serum Thyroid-stimulating Hormone (TSH) and Intracytoplasmic Sperm Injection (ICSI) Outcome in Women Undergoing ICSI","status":"COMPLETED","sponsor":"Cairo University","startDate":"2019-01-01","conditions":"Infertility, Female","enrollment":180},{"nctId":"NCT07457255","phase":"NA","title":"Late Endocrine and Metabolic Consequences After Childhood Brain Tumor Treatment","status":"COMPLETED","sponsor":"Institute of Oncology Ljubljana","startDate":"2023-01-01","conditions":"Childhood Brain Tumors, Endocrine Disorders","enrollment":12},{"nctId":"NCT04723810","phase":"PHASE1, PHASE2","title":"TumorGlow Intraoperative Molecular Imaging (IMI)","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2024-08-14","conditions":"Tumor, Solid","enrollment":500},{"nctId":"NCT06226545","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease","status":"COMPLETED","sponsor":"Lassen Therapeutics Inc.","startDate":"2024-03-05","conditions":"Thyroid Eye Disease, Graves Ophthalmopathy, Graves Orbitopathy","enrollment":41},{"nctId":"NCT01109420","phase":"","title":"Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2010-08-12","conditions":"Non-Medullary Thyroid Cancer","enrollment":500},{"nctId":"NCT02568267","phase":"PHASE2","title":"Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2015-11-19","conditions":"Breast Cancer, Cholangiocarcinoma, Colorectal Cancer","enrollment":534},{"nctId":"NCT07454044","phase":"NA","title":"Nurse-Led Emotional Freedom Technique for Preoperative Anxiety and Fear in Thyroid Surgery","status":"NOT_YET_RECRUITING","sponsor":"Saglik Bilimleri Universitesi","startDate":"2026-02-09","conditions":"Preoperative Anxiety, Fear and Anxiety, Thyroid Surgery","enrollment":70},{"nctId":"NCT03570021","phase":"PHASE3","title":"ESTIMation of the ABiLity of Prophylactic Central Compartment Neck Dissection to Modify Outcomes in Low-risk Differentiated Thyroid Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2018-08-08","conditions":"Thyroid Cancer","enrollment":352},{"nctId":"NCT03083405","phase":"","title":"Selected Disorders and Sleep Bruxism","status":"ENROLLING_BY_INVITATION","sponsor":"Wroclaw Medical University","startDate":"2017-04-20","conditions":"Sleep Bruxism, Hypertension, Thyroid Dysfunction","enrollment":100},{"nctId":"NCT03573960","phase":"PHASE4","title":"A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer","status":"COMPLETED","sponsor":"Eisai Pharmaceuticals India Pvt. Ltd","startDate":"2018-04-01","conditions":"Thyroid Neoplasms","enrollment":50},{"nctId":"NCT07018323","phase":"PHASE2","title":"A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease","status":"RECRUITING","sponsor":"Immunovant Sciences GmbH","startDate":"2025-06-19","conditions":"Graves' Disease","enrollment":210},{"nctId":"NCT07453290","phase":"","title":"Dysregulation of the Soluble α-Klotho-FGF23 Axis in Hashimoto's Thyroiditis: A Case-Control Study","status":"NOT_YET_RECRUITING","sponsor":"Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital","startDate":"2026-03-02","conditions":"Autoimmune Thyroiditis","enrollment":150},{"nctId":"NCT05604963","phase":"NA","title":"Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers","status":"RECRUITING","sponsor":"University College, London","startDate":"2022-02-14","conditions":"Differentiated Thyroid Cancer","enrollment":456},{"nctId":"NCT04216732","phase":"","title":"Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-01-10","conditions":"Advanced Thyroid Gland Medullary Carcinoma, Stage III Thyroid Gland Medullary Carcinoma AJCC v8, Stage IV Thyroid Gland Medullary Carcinoma AJCC v8","enrollment":2030},{"nctId":"NCT07445659","phase":"NA","title":"qCON/qNOX-Guided Anesthesia in Patients Undergoing Thyroidectomy Surgery","status":"NOT_YET_RECRUITING","sponsor":"Kayseri City Hospital","startDate":"2026-03-15","conditions":"Thyroid Surgeries, Intraoperative Analgesic Use, Anesthesia Depth Monitoring","enrollment":90},{"nctId":"NCT07453225","phase":"PHASE1, PHASE2","title":"Empirical Radioactive Iodine Therapy in DTC","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-04-01","conditions":"Differentiated Thyroid Cancer","enrollment":100},{"nctId":"NCT05607407","phase":"PHASE2","title":"Methimazole in Patients With Progressive Glioblastoma","status":"RECRUITING","sponsor":"Case Comprehensive Cancer Center","startDate":"2023-01-30","conditions":"Glioblastoma, Glioma","enrollment":19},{"nctId":"NCT07447089","phase":"NA","title":"EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study","status":"RECRUITING","sponsor":"Università Cattolica di Milano","startDate":"2025-12-05","conditions":"Thyroid Neoplasms, Neoplasm, Post-traumatic Stress Disorder (PTSD)","enrollment":25},{"nctId":"NCT02597426","phase":"","title":"Nasopharyngeal Carcinoma Post IMRT","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2015-06","conditions":"Nasopharyngeal Carcinoma","enrollment":108},{"nctId":"NCT07305818","phase":"PHASE1","title":"NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease","status":"RECRUITING","sponsor":"Merida Biosciences","startDate":"2025-12-19","conditions":"Graves Disease","enrollment":100},{"nctId":"NCT07444190","phase":"","title":"Psychological Burden of Thyroid Eye Disease","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2025-01-01","conditions":"Thyroid Eye Disease, TED","enrollment":20},{"nctId":"NCT02185560","phase":"","title":"Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bayer","startDate":"2014-06-27","conditions":"Thyroid Carcinoma","enrollment":453},{"nctId":"NCT07286006","phase":"PHASE2","title":"A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)","status":"ENROLLING_BY_INVITATION","sponsor":"Immunovant Sciences GmbH","startDate":"2026-01-26","conditions":"Graves' Disease","enrollment":372},{"nctId":"NCT04321954","phase":"PHASE2","title":"Lenvatinib in Locally Advanced Invasive Thyroid Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2021-03-09","conditions":"Differentiated Thyroid Cancer, Advanced Cancer","enrollment":30},{"nctId":"NCT06554652","phase":"PHASE3","title":"Selective Neck Dissection Versus Modified Neck Dissection in PTC","status":"RECRUITING","sponsor":"Fudan University","startDate":"2024-11-19","conditions":"Thyroid Cancer","enrollment":250},{"nctId":"NCT06891118","phase":"NA","title":"Stellate Ganglion Blockade for Refractory Chronic Migraine","status":"COMPLETED","sponsor":"Ankara City Hospital Bilkent","startDate":"2024-03-06","conditions":"Headache, Migraine, Chronic Migraine Headache","enrollment":42},{"nctId":"NCT07142642","phase":"PHASE1","title":"A Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Teprotumumab (AMG 632) Administered Intravenously in Healthy Chinese Participants","status":"COMPLETED","sponsor":"Amgen","startDate":"2025-08-26","conditions":"Healthy Volunteers","enrollment":20},{"nctId":"NCT05907304","phase":"PHASE1","title":"A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations","status":"ACTIVE_NOT_RECRUITING","sponsor":"Erasca, Inc.","startDate":"2023-08-17","conditions":"Advanced or Metastatic Solid Tumors","enrollment":86},{"nctId":"NCT07438405","phase":"PHASE2","title":"An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease","status":"NOT_YET_RECRUITING","sponsor":"Amgen","startDate":"2026-02-25","conditions":"Thyroid Eye Disease","enrollment":30},{"nctId":"NCT06558981","phase":"PHASE3","title":"Adjuvant Radiotherapy in High Risk Locally Advanced DTC","status":"RECRUITING","sponsor":"Fudan University","startDate":"2024-07-11","conditions":"Thyroid Cancer","enrollment":124},{"nctId":"NCT07193186","phase":"PHASE2","title":"Anlotinib and Benmelstobart in DTC","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2026-04-01","conditions":"Thyroid Cancer","enrollment":23}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":9,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["AGN-282176","Desiccated thyroid extract","AGN-204771"],"phase":"marketed","status":"active","brandName":"Armour Thyroid","genericName":"Armour Thyroid","companyName":"AbbVie","companyId":"abbvie","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Armour Thyroid replaces deficient thyroid hormones by providing a combination of T4 (levothyroxine) and T3 (liothyronine) derived from desiccated porcine thyroid tissue. Used for Hypothyroidism (primary, secondary, and tertiary), Myxedema.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}